The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

APGE FINANCIAL STATEMENTS

Apogee Therapeutics, Inc. Common Stock — balance sheet, income statement and cash flow trends

APGEApogee Therapeutics, Inc. Common Stock

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-300 M-200 M-100 M020222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue0 $Gross Profit-408 K $ · -Infinity%Operating Income-328.1 M $ · -Infinity%Pre-tax Income-294.1 M $ · -Infinity%Net Income to Owners-294.4 M $ · -Infinity%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue0 $-100.0%
Gross Profit-408 K $—
Operating Income-328.1 M $—
EBITDA-291.3 M $—
Net Income to Owners-294.4 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0500 M1 B20222023202420252026

Capital Structure

Q2 2026
Total Assets1.3 B
  • Equity1.2 B $89%
  • Current Liabilities37.5 M $3%
  • Long-term Liabilities103.7 M $8%

Key Figures

YoY change
Total Assets1.3 B $+103.1%
Total Liabilities141.2 M $+268.0%
Total Equity1.2 B $+92.9%
Cash & ST Investments971.9 M $+92.3%
Total Debt6.8 M $-37.0%
Net Debt-98.7 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-200 M-100 M020222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-500 M0-243.9 M $Operating-687.9 M $Investing912.9 M $Financing-18.9 M $Net Change

Key Figures

YoY change
Operating Cash Flow-243.9 M $—
Capital Expenditures68 K $-98.8%
Free Cash Flow-244 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on APGE

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.